BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19023520)

  • 21. Management of meningiomas.
    Alexiou GA; Gogou P; Markoula S; Kyritsis AP
    Clin Neurol Neurosurg; 2010 Apr; 112(3):177-82. PubMed ID: 20056312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current experimental therapies for atypical and malignant meningiomas.
    Corona AM; Di L; Shah AH; Crespo R; Eichberg DG; Lu VM; Luther EM; Komotar RJ; Ivan ME
    J Neurooncol; 2021 Jun; 153(2):203-210. PubMed ID: 33950341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal treatment of parasagittal meningiomas: a single-center experience.
    Gatterbauer B; Gevsek S; Höftberger R; Lütgendorf-Caucig C; Ertl A; Mallouhi A; Kitz K; Knosp E; Frischer JM
    J Neurosurg; 2017 Dec; 127(6):1249-1256. PubMed ID: 28156245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactory groove meningioma.
    Adappa ND; Lee JY; Chiu AG; Palmer JN
    Otolaryngol Clin North Am; 2011 Aug; 44(4):965-80, ix. PubMed ID: 21819883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy for unresectable meningiomas: benign and malignant.
    Chen TC; Chamberlain MC
    Neurosurg Focus; 2007; 23(4):1. PubMed ID: 18081514
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent meningioma.
    Boylan SE; McCunniff AJ
    Cancer; 1988 Apr; 61(7):1447-52. PubMed ID: 3278800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Related mechanisms, current treatments, and new perspectives in meningioma.
    Inetas-Yengin G; Bayrak OF
    Genes Chromosomes Cancer; 2024 May; 63(5):e23248. PubMed ID: 38801095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical therapies for meningiomas.
    Wen PY; Quant E; Drappatz J; Beroukhim R; Norden AD
    J Neurooncol; 2010 Sep; 99(3):365-78. PubMed ID: 20820875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic meningioma: case report.
    Falavigna A; Santos JA; Chimelli L; Ferraz FA; Bonatelli Ad Ade P
    Arq Neuropsiquiatr; 2001 Dec; 59(4):939-43. PubMed ID: 11733842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial Meningiomas: A 30-Year Experience and Literature Review.
    Mehdorn HM
    Adv Tech Stand Neurosurg; 2016; (43):139-84. PubMed ID: 26508409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and Prognostic Predictors of Anaplastic Meningiomas.
    Masalha W; Heiland DH; Delev D; Fennell JT; Franco P; Scheiwe C; Mercas BI; Mader I; Schnell O; Grauvogel J
    World Neurosurg; 2019 Nov; 131():e321-e328. PubMed ID: 31356972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR-guided laser interstitial thermal therapy in the treatment of recurrent intracranial meningiomas.
    Rammo R; Scarpace L; Nagaraja T; Lee I
    Lasers Surg Med; 2019 Mar; 51(3):245-250. PubMed ID: 30592538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
    Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
    Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of atypical and anaplastic meningiomas: a review.
    Modha A; Gutin PH
    Neurosurgery; 2005 Sep; 57(3):538-50; discussion 538-50. PubMed ID: 16145534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy for meningiomas.
    Kyritsis AP
    J Neurooncol; 1996 Sep; 29(3):269-72. PubMed ID: 8858533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
    Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric meningiomas: 65-year experience at a single institution.
    Grossbach AJ; Mahaney KB; Menezes AH
    J Neurosurg Pediatr; 2017 Jul; 20(1):42-50. PubMed ID: 28474981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.
    Yew A; Trang A; Nagasawa DT; Spasic M; Choy W; Garcia HM; Yang I
    J Clin Neurosci; 2013 Jan; 20(1):17-22. PubMed ID: 22743042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.